Khaled Greish

Title: Khaled Greish: Innovator in Cancer Gene Therapy

Introduction

Khaled Greish is a prominent inventor based in Salt Lake City, UT. He has made significant contributions to the field of cancer gene therapy through his innovative research and development of advanced delivery systems.

Latest Patents

Khaled Greish holds a patent for "Matrix metalloproteinase cleavable protein polymers for cancer gene therapy." This delivery system includes a recombinantly synthesized protein polymer with protease cleavage sites, such as matrix metalloproteinase responsive sequences engineered within the protein polymer. The system is designed to treat cancer, wounds, or pathological conditions in tissues that express excess protease relative to healthy tissue. He has 1 patent to his name.

Career Highlights

Khaled Greish is affiliated with the University of Utah Research Foundation, where he continues to advance his research in the field of gene therapy. His work focuses on developing innovative solutions that can improve treatment outcomes for patients suffering from cancer and other related conditions.

Collaborations

Khaled has collaborated with notable colleagues, including Hamidreza Ghandehari and Joseph Cappello, to further enhance the impact of his research and innovations.

Conclusion

Khaled Greish is a dedicated inventor whose work in cancer gene therapy exemplifies the potential of innovative research to transform medical treatments. His contributions are paving the way for new therapeutic strategies that could significantly benefit patients in need.